(Q51925691)

17 April 2018

title

Costs versus benefits: best possible and best practical treatment regimens for HIV. (English)

1 reference

17 April 2018

author name string

O Krakovska

series ordinal

1

1 reference

17 April 2018

L M Wahl

series ordinal

2

1 reference

17 April 2018

publication date

5 January 2007

1 reference

17 April 2018

number of pages

22

1 reference

Journal of Mathematical Biology

inferred from page(s)

published in

1 reference

17 April 2018

volume

54

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

385-406

1 reference

17 April 2018

maintained by WikiProject

WikiProject Mathematics

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00285-006-0059-1

0 references

cites work

Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection

1 reference

https://api.crossref.org/works/10.1007%2FS00285-006-0059-1

Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-006-0059-1

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-006-0059-1

Discrete event modeling of CD4+ memory T cell generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-006-0059-1

Protein binding in antiretroviral therapies

21 January 2018

1 reference

12 December 2020

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

12 December 2020

Virus dynamics and drug therapy

1 reference

12 December 2020

The implications of drug resistance for strategies of combination antiviral chemotherapy.

1 reference

12 December 2020

Predicting differential responses to structured treatment interruptions during HAART.

1 reference

12 December 2020

Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells

1 reference

12 December 2020

Pre-existence and emergence of drug resistance in HIV-1 infection.

1 reference

12 December 2020

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

12 December 2020

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy

1 reference

12 December 2020

Stochastic optimal therapy for enhanced immune response.

1 reference

12 December 2020

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

12 December 2020

A model for treatment strategy in the chemotherapy of AIDS.

1 reference

12 December 2020

Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

1 reference

12 December 2020

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

1 reference

12 December 2020

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

12 December 2020

Adherence and drug resistance: predictions for therapy outcome

1 reference

12 December 2020

Boosting immunity by antiviral drug therapy: a simple relationship among timing, efficacy, and success

1 reference

12 December 2020

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

12 December 2020

A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.

1 reference

12 December 2020

Plasma viral load, CD4+ cell counts, and HIV-1 production by cells

1 reference

12 December 2020

Treatment interruption in HIV therapy: a SMART strategy?

1 reference

12 December 2020

The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

1 reference

12 December 2020

Mutation takes no vacation: can structured treatment interruptions increase the risk of drug-resistant HIV-1?

1 reference

12 December 2020

Dynamic multidrug therapies for hiv: optimal and sti control approaches.

1 reference

12 December 2020

Optimal HIV treatment by maximising immune response.

1 reference

12 December 2020

When to initiate hiv therapy: a control theoretic approach

1 reference

12 December 2020

Latent reservoirs of HIV: obstacles to the eradication of virus

1 reference

12 December 2020

In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

1 reference

12 December 2020

Dynamics and evolution of HIV-1 during structured treatment interruptions.

1 reference

12 December 2020

Optimal control of the chemotherapy of HIV.

1 reference

12 December 2020

Dynamic multidrug therapies for HIV: a control theoretic approach.

1 reference

12 December 2020

10.1007/S00285-006-0059-1

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018